Literature DB >> 11900609

Alcohol and upper gastrointestinal tract cancer: the role of local acetaldehyde production.

Nils Homann1.   

Abstract

Alcohol is, together with tobacco smoke, the main cause for upper GI tract cancer in industrialized countries. However, the tumour-promoting effects of alcohol intake are poorly understood and alcohol itself is not carcinogenic in the animal model. There is increasing evidence that alcohol metabolism, rather than the alcohol itself, generates carcinogenic and cell-toxic compounds. Acetaldehyde, first metabolite of ethanol, is highly toxic, mutagenic and carcinogenic. Polymorphisms in the genes coding for enzymes responsible for acetaldehyde accumulation and detoxification have been associated with an increased cancer risk. Acetaldehyde can also be produced in the mucosa and by the physiological microflora. This review summarizes the scientific evidence that alcohol intake leads to a local production of acetaldehyde. It describes the role of the oral microflora, the mucosa and the salivary glands in this process and shows that local acetaldehyde production from ethanol may contribute to the carcinogenesis of alcohol intake in the upper GI tract.

Entities:  

Year:  2001        PMID: 11900609     DOI: 10.1080/13556210020077028

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  20 in total

Review 1.  Microbiome and cancer.

Authors:  Naoko Ohtani
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

Review 2.  The gut microbiota, bacterial metabolites and colorectal cancer.

Authors:  Petra Louis; Georgina L Hold; Harry J Flint
Journal:  Nat Rev Microbiol       Date:  2014-09-08       Impact factor: 60.633

Review 3.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

4.  Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma.

Authors:  A W L Bayci; D A Baker; A E Somerset; O Turkoglu; Z Hothem; R E Callahan; R Mandal; B Han; T Bjorndahl; D Wishart; R Bahado-Singh; S F Graham; R Keidan
Journal:  Metabolomics       Date:  2018-08-03       Impact factor: 4.290

5.  The activity of class I, II, III, and IV alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in esophageal cancer.

Authors:  Wojciech Jelski; Miroslaw Kozlowski; Jerzy Laudanski; Jacek Niklinski; Maciej Szmitkowski
Journal:  Dig Dis Sci       Date:  2008-08-09       Impact factor: 3.199

6.  The activity of class I, II, III, and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in colorectal cancer.

Authors:  Wojciech Jelski; Bogdan Zalewski; Lech Chrostek; Maciej Szmitkowski
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

Review 7.  Gut microbiota imbalance and colorectal cancer.

Authors:  Johan Gagnière; Jennifer Raisch; Julie Veziant; Nicolas Barnich; Richard Bonnet; Emmanuel Buc; Marie-Agnès Bringer; Denis Pezet; Mathilde Bonnet
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

8.  Multiple alcohol dehydrogenases but no functional acetaldehyde dehydrogenase causing excessive acetaldehyde production from ethanol by oral streptococci.

Authors:  Sylvia I Pavlova; Ling Jin; Stephen R Gasparovich; Lin Tao
Journal:  Microbiology       Date:  2013-05-01       Impact factor: 2.777

9.  Short-term salivary acetaldehyde increase due to direct exposure to alcoholic beverages as an additional cancer risk factor beyond ethanol metabolism.

Authors:  Dirk W Lachenmeier; Yulia B Monakhova
Journal:  J Exp Clin Cancer Res       Date:  2011-01-06

10.  Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.

Authors:  Wojciech Filipiak; Andreas Sponring; Tomas Mikoviny; Clemens Ager; Jochen Schubert; Wolfram Miekisch; Anton Amann; Jakob Troppmair
Journal:  Cancer Cell Int       Date:  2008-11-24       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.